Encorafenib (Braftovi) is a targeted therapy indicated for the treatment of cancers with specific gene mutations, such as melanoma, colorectal cancer, and non-small cell lung cancer. As a prescription medication, its procurement and administration must be strictly conducted under medical supervision.

What Are the Procurement Channels for Encorafenib (Braftovi)?

Overseas Procurement

Patients may consult and purchase the drug at hospital pharmacies or licensed retail pharmacies in countries/regions where Encorafenib has been approved for marketing.

Given that drug prices may be affected by factors such as regional variations and exchange rate fluctuations, patients are advised to make a detailed budget and plan in advance before purchasing.

Procurement via Medical Service Institutions

Patients may consult domestic overseas medical service institutions that have established partnerships with international pharmacies or pharmaceutical manufacturers.

These institutions typically provide legitimate import channels, along with professional consulting and guidance services.

Precautions for Procuring Encorafenib (Braftovi)

Adhere to Medical Prescriptions Strictly and Purchase Only with a Valid Prescription

Encorafenib is exclusively indicated for patients with confirmed BRAF V600E or V600K mutations detected by FDA-approved testing methods.

A specialist physician must conduct an evaluation and issue a prescription prior to purchase. Self-procurement and self-administration are strictly prohibited.

Verify That Drug Information Matches the Prescription

Brand Name: BRAFTOVI®.

Generic Name: Encorafenib.

Dosage Form: 75 mg per capsule.

Manufacturer: Produced by Array BioPharma Inc., a subsidiary of Pfizer Inc.

Inspect Drug Packaging and Storage Conditions.

Check the outer packaging for integrity and signs of tampering.

Ensure that the desiccant packet inside the drug bottle is intact and has not been removed.

Encorafenib should be stored at room temperature (20°C–25°C). At the time of purchase, verify that the storage conditions of the pharmacy or hospital comply with this requirement.

How to Distinguish Authentic Encorafenib (Braftovi) from Counterfeit Products

Examine Outer Packaging and Labels

Print Quality: Authentic packaging features clear printing, uniform coloration, and standard font. Counterfeit packaging often has blurred printing, color discrepancies, and spelling errors.

Anti-Counterfeiting Labels: Check for official anti-counterfeiting labels or scannable barcodes/QR codes on the packaging for verification.

Approval Number: While the format of approval numbers varies by country, all legitimate medications must carry a number issued by the national drug regulatory authority, which can be verified through official channels.

Inspect the Medication Itself

Capsule Appearance: Authentic Encorafenib capsules are hard gelatin capsules with an off-white cap imprinted with a stylized "A" and a white body imprinted with "LGX 75mg". Carefully compare the capsule color and the clarity of the imprints.

Medication Characteristic: Capsules should be intact, without cracks, adhesion, or leakage of contents.